Investment Success for MindWeavers Plc
MindWeavers set to launch new products for Brain Health market.
MindWeavers set to launch new products for Brain Health market.
Technology merger offers advantages for next generation flat panel displays and lighting applications.
BioAnalab Limited, the Oxford-based specialist contract analytical laboratory, today announced the successful completion of a further round of private equity funding totalling £440,000. The round was led by Octopus Asset Management, who invested £250,000 through the BioScience Venture Capital Trust.
BioAnaLab Limited, a specialist contract analytical laboratory, has recently published its annual accounts for 2003-2004.
Oxford University has signed a private equity deal, initially worth £12m, to help the funding of its new Institute of Biomedical Engineering (IBME) www.ibme.ox.ac.uk. The deal, struck with London’s City-based Technikos, also includes the provision of commercial and financial advice and assistance in return for shares in future spin-outs from IBME.
A new report from Oxford University Innovation, the University of Oxford’s technology transfer company, celebrates 10 years of the Oxford University Challenge Seed Fund, showing how the Fund has helped turn research ideas into commercial success stories.
Oxford Advanced Surfaces (“OAS”), a spin-out company of the University of Oxford, has listed on the Alternative Investment Market (AIM), and has achieved a market capitalisation of £84.5 million
Oxford Immunotec – a 2002 Isis spin-out – has raised US$64 million in an IPO on America’s Nasdaq stock exchange. The Abingdon-based company sells diagnostic tests for latent tuberculosis infection, T-SPOT®.TB.
Isis Enterprise is to work with Oxford’s Saïd Business School on hosting scholarships for India’s future leaders in science, business and government, the Prime Minister announced last week.
Oxford University Innovation Ltd is a growing and profitable business owned by the University of Oxford.